Diagnostic value of pleural effusion ischaemia-modified albumin in patients with cardiac failure

Annals of Clinical Biochemistry

Volumn 48, Issue 1, 2011, Pages 45-50

  Ozsu, Savas ^a   Gulsoy, Ayhan ^a   Karahan, S Caner ^a   Mentese, Ahmet ^a   Nuhoglu, Irfan ^a   Ozlu, Tevfik ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ISCHEMIA MODIFIED ALBUMIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; LUNG EMBOLISM; MALE; NEOPLASM; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE DIAGNOSIS; SENSITIVITY AND SPECIFICITY;

AGED; BIOLOGICAL MARKERS; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PLEURAL EFFUSION; PREDICTIVE VALUE OF TESTS; SERUM ALBUMIN;

EID: 79551477977     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2010.010159     Document Type: Article

References (26)

1. Romero-Candeira S, Fernandez C, Martin C, Esquerda A, Ruiz-Gonzalez A, Vives M. Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heartfailure. Am J Med 2001;110:681-6
2. Aleman C, Sanchez L, Alegre J, et al. Differentiating between malignant and idiopathic pleural effusions: the value of diagnostic procedures. Q J Med 2007;100:351-9 (Pubitemid 47073811)
3. Peacock F, Morris DL, Anwaruddin S, et al. Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J 2006;152:253-62
4. Keating L, Benger JR, Beetham R, et al. The PRIMA study: presentation of ischemia modified albumin in the emergency department. Emerg Med J 2006;23:764-8
5. Sinha MK, Gaze DC, Tippins JR, Collinson PO, Kaski JC. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 2003;107:2403-5
6. Refaai MA, Wright RW, Parwin CA, Gronowski AM, Scott MG, Eby CS. Ischemia-modified albumin increases after skeletal muscle ischemia during arthroscopic knee surgery. Clin Chim Acta 2006;366:264-8
7. Turedi S, Gunduz A, Mentese A, et al. The value of ischemia-modified albumin in the diagnosis of pulmonary embolism. Am J Emerg Med 2007;25:770-3 (Pubitemid 47385040)
8. Mentese A, Mentese U, Turedi S, et al. Effect of deep vein thrombosis on ischaemia-modified albumin levels. Emerg Med J 2008;25:811-4
9. Abboud H, Labreuche J, Meseguer E, et al. Ischemia-modified albumin in acute stroke. Cerebrovasc Dis 2007;23:216-20
10. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ, Samimi-Fard S, Kaski JC. Relation of ischemia-modified albumin levels and left ventricular systolic function in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Clin Chim Acta 2008;388:196-9
11. Sbarouni E, Georgiadou P, Koutelou M, Sklavainas I, Pangiotakos D, Voudris V. Ischemia-modified albumin in dilated cardiomyopathy. Ann Clin Biochem 2009;46:241-3
12. Davies CWH, Gleeson FV, Davies RJO. BTS guidelines for the management of pleural infection. Thorax 2003;58(suppl):18-28
13. Torbicki A, Penier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2008;29:2276-315
14. Bar-Or D, Lau E, Winkler JV. Novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia - a preliminary report. J Emerg Med 2000;19:311-5
15. Kolditz M, Halank M, Schiemanck CS, Schmeisser A, Hoffken G. High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions. Eur Respir J 2006;28:144-50 (Pubitemid 44914272)
16. Zemans RL, Chatterjee K, Matthay A. Diagnostic utility of B-type natriuretic peptide in patients with acute dyspnea or pleural effusions. Am J Med 2004;116:424-6
17. Light RW. Use of pleural fluid N-terminal-pro-brain natriuretic peptide and brain natriuretic peptide in diagnosing pleural effusion due to congestive heart failure. Chest 2009;136:656-8
18. Sbarouni E, Georgiadou P, Th. Kremastinos D, Voudris V. Ischemia modified albumin: is this marker of ischemia ready for prime time use? Hellenic J Cardiol 2008;49:260-6
19. Porcel JM, Chorda J, Cao G, Sanchez-Paya J, Hernandez L. Comparing serum and pleural fluid pro-brain natriuretic peptide (NT-proBNP) levels with pleural-to-serum albumin gradient for the identification of cardiac effusions misclassified by Light's criteria. Respirology 2007;12:654-9
20. Tomcsanyi J, Nagy E, Somloi M, et al. NT-brain natriuretic peptide levels in pleural fluid distinguish between pleural transudates and exudates. Eur J Heart Fail 2004;6:753-6 (Pubitemid 39470230)
21. Porcel JM, Martinez-Alonso M, Cao G, Bielsa S, Sopena A, Esquerda A. Biomarkers of heart failure in pleural fluid. Chest 2009;136:671-7
22. Liao H, Na MJ, Dikensoy O, Lane KB, Randal B, Light RW. Diagnostic value of pleural fluid N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases. Respirology 2008;13:53-7
23. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol 2007;50:2357-68
24. Marrow DA, de Lemos JA. Bench-marks for the assessment of novel cardiovascular biomarkers. Circulation 2007;115:949-52
25. Fremont B, Pacouret G, Jacobi D, Puglisi R, Charbonnier B, de Labriolle A. Prognostic value of the echocardiographic right/left ventricular end-diastolic diameter ratio in patients with acute pulmonary embolism: results from a monocenter registry of 1416 patients. Chest 2008;133:358-62
26. Goldhaber SZ, Visani L, De M. Acute pulmonary embolism: clinical outcomes in International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999;353:1386-9